carfilzomib / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
carfilzomib / Generic mfg.
NCT03416374: A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy

Completed
4
45
Japan
Ixazomib, Bortezomib, Carfilzomib, Lenalidomide, Dexamethasone
Takeda
Relapsed and/or Refractory Multiple Myeloma
05/21
05/21
NCT03934684: Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Active, not recruiting
4
101
RoW
Drug: Carfilzomib + Dexamethasone, Kyprolis, Drug: Carfilzomib + Lenalidomide + Dexamethasone
Amgen
Relapsed Refractory Multiple Myeloma
03/23
06/25

Download Options